Physician profile
Dara E Schroeder
NPI 1740501386
$1,025.77
in general payments reported to CMS, 2019-2025
10 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2022: $205 · 2023: $168 · 2024: $363 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $465.88 | 2024-2025 | |
| Abbvie INC. | $176.63 | 2021-2024 | |
| Astellas Pharma US INC | $175.97 | 2022-2023 | Veozah, Myrbetriq |
| Novartis Pharmaceuticals Corporation | $46.19 | 2021-2022 | |
| Abbott Laboratories | $34.48 | 2022-2023 | Freestyle Libre 2 |
| Lilly USA, LLC | $32.31 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.25 | 2021-2022 | |
| Novo Nordisk INC | $25.29 | 2021 | |
| Amgen INC. | $24.99 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $16.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dara Schroeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.